LBI-HTA - Publications - Search - Avastin for Age-related Macular-Degeneration. Evidence synthesis after CATT, IVAN, MANTA

Wild, C. (2012): Avastin for Age-related Macular-Degeneration. Evidence synthesis after CATT, IVAN, MANTA. Rapid Assessment 005.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
1156Kb
Abstract

Background: Synthesis of evidence on the efficacy and safety of Avastin for AMD

Method: Assessment of three head-to-head RCTs on Avastin for AMD

Results: Since the publication of now three head-to-head randomised clinical studies / RCTs (CATT, IVAN, MANTA), evidence meeting the highest methodological requirements is available. The efficacy is regarded – not least by these RCTs – as proven. According to CATT, IVAN and MANTA, a discussion about the equivalence is no longer necessary, but probably about the monthly vs. needs-oriented administration strategy, since with the latter the intravitreal injections have to be administered considerably less frequently.

Conclusion: A legal regulation is urgently pending in Austria in order to place evidence-based, off-label application on a legal foundation (with regard to liability and insurance laws).

Item Type:Rapid Assessment LBI-HTA
Keywords:AMD, Age-related Macular Degeneration, off-label use, Avastin, Bevacizumab, Ophthalmology
Subjects:WW Ophthalmology > WW 270 Retina
WB Practice of medicine > WB 60 Bioethics. Clinical ethics. Clinical ethics committees
W Health professions > W 74-80 Medical economics. Health care costs
WB Practice of medicine > WB 102 Evidence-based medicine
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
WW Ophthalmology > WW 101-170 Eye
Language:German
Series Name:Rapid Assessment 005
Deposited on:21 Jan 2013 15:38
Last Modified:23 Jan 2013 12:36

Repository Staff Only: item control page